In xenograft models, ATF3 knockdown compromised the antitumor efficacy of AQB+CBPt, as evidenced by accelerated tumor growth and higher Ki-67 staining (Supplementary Fig. S6G–K). This evidence concerns the gene ATF3 and neoplasm.